78 related articles for article (PubMed ID: 11490228)
1. Complex perioperative immuno-dysfunction in patients with renal cell carcinoma.
Böhm M; Ittenson A; Philipp C; Röhl FW; Ansorge S; Allhoff EP
J Urol; 2001 Sep; 166(3):831-6. PubMed ID: 11490228
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
Böhm M; Ittenson A; Klatte T; Schierbaum KF; Röhl FW; Ansorge S; Allhoff EP
Folia Biol (Praha); 2003; 49(2):63-8. PubMed ID: 12779014
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with interleukin-2 modulates peri-operative immuno-dysfunction in patients with renal cell carcinoma.
Böhm M; Ittenson A; Schierbaum KF; Röhl FW; Ansorge S; Allhoff EP
Eur Urol; 2002 Apr; 41(4):458-67; discussion 467-8. PubMed ID: 12074819
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinoma.
Landman J; Olweny E; Sundaram CP; Chen C; Rehman J; Lee DI; Shalhav A; Portis A; McDougall EM; Clayman RV
J Urol; 2004 Apr; 171(4):1456-60. PubMed ID: 15017197
[TBL] [Abstract][Full Text] [Related]
5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
6. Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.
Lauerová L; Dusek L; Spurny V; Simicková M; Rovny A; Rejthar A; Kocák I; Kovarík J
Oncol Rep; 2001; 8(3):685-92. PubMed ID: 11295103
[TBL] [Abstract][Full Text] [Related]
7. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
Verra N; de Jong D; Bex A; Batchelor D; Dellemijn T; Sein J; Nooijen W; Meinhardt W; Horenblas S; de Gast G; Vyth-Dreese F
Eur Urol; 2005 Sep; 48(3):527-33. PubMed ID: 16115526
[TBL] [Abstract][Full Text] [Related]
9. Soluble immunological parameters and early prognosis of renal cell cancer patients.
Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines and soluble cytokine receptors in the perioperative period].
Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
[TBL] [Abstract][Full Text] [Related]
11. Monitoring peri-operative immune suppression in renal cancer patients.
Hase S; Weinitschke K; Fischer K; Fornara P; Hoda R; Unverzagt S; Seliger B; Riemann D
Oncol Rep; 2011 May; 25(5):1455-64. PubMed ID: 21369703
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
13. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
14. [Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma].
Shi B; Nakazawa H; Ryoji O; Goya N; Ito F; Koga S; Okuda H; Kobayashi H; Toma H
Hinyokika Kiyo; 1998 Mar; 44(3):143-7. PubMed ID: 9589873
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
16. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
van der Vliet HJ; Koon HB; Yue SC; Uzunparmak B; Seery V; Gavin MA; Rudensky AY; Atkins MB; Balk SP; Exley MA
Clin Cancer Res; 2007 Apr; 13(7):2100-8. PubMed ID: 17404092
[TBL] [Abstract][Full Text] [Related]
17. Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial.
Klatte T; Ittenson A; Röhl FW; Ecke M; Allhoff EP; Böhm M
Br J Cancer; 2006 Nov; 95(9):1167-73. PubMed ID: 17031403
[TBL] [Abstract][Full Text] [Related]
18. Abdominal surgical interventions: local and systemic consequences for the immune system--a prospective study on elective gastrointestinal surgery.
Decker D; Tolba R; Springer W; Lauschke H; Hirner A; von Ruecker A
J Surg Res; 2005 Jun; 126(1):12-8. PubMed ID: 15916969
[TBL] [Abstract][Full Text] [Related]
19. Characterization of primary renal carcinoma cultures.
Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma.
Klatte T; Ittenson A; Röhl FW; Ecke M; Allhoff EP; Böhm M
Onkologie; 2008 Feb; 31(1-2):28-34. PubMed ID: 18268396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
